Cargando…

Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017

BACKGROUND: Trachoma is a contagious infection of the eye by specific strains of the bacteria Chlamydia trachomatis. It is the leading cause of blindness worldwide. Mass drug administration (MDA) with azithromycin is a cornerstone of World Health Organization (WHO)’s global effort to eliminate trach...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekuma, Tariku Tesfaye, Mosisa Kebebew, Getu, Desalegn Waktole, Zelalem, Markos Cafo, Jote, Wirtu, Desalegn, Gaddisa, Solomon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936871/
https://www.ncbi.nlm.nih.gov/pubmed/31841516
http://dx.doi.org/10.1371/journal.pntd.0007924
_version_ 1783483781316870144
author Bekuma, Tariku Tesfaye
Mosisa Kebebew, Getu
Desalegn Waktole, Zelalem
Markos Cafo, Jote
Wirtu, Desalegn
Gaddisa, Solomon
author_facet Bekuma, Tariku Tesfaye
Mosisa Kebebew, Getu
Desalegn Waktole, Zelalem
Markos Cafo, Jote
Wirtu, Desalegn
Gaddisa, Solomon
author_sort Bekuma, Tariku Tesfaye
collection PubMed
description BACKGROUND: Trachoma is a contagious infection of the eye by specific strains of the bacteria Chlamydia trachomatis. It is the leading cause of blindness worldwide. Mass drug administration (MDA) with azithromycin is a cornerstone of World Health Organization (WHO)’s global effort to eliminate trachoma by 2020. This coverage survey was aimed to assess trachoma post-mass drug administration (MDA) coverage among six selected districts of East Wollega, Horo Guduru Wollega, and West Shewa zones in2017. METHODS: A community based cross-sectional coverage survey was conducted. The sample size was calculated automatically using Coverage Survey Builder (CSB) tool in microsoft excel. Thirty segments were selected per each selected districts of the three zones. A separate Results Entry Form for each district surveyed was completed, saved and uploaded directly into the online Coverage Survey Analysis Tool to estimate the surveycoverage and the program reach along with the corresponding 95% confidence limits and design effects. EPI-INFO 7.0 and SPSS version 20 was used for further analysis of survey data. RESULT: A total of 1,747 households were surveyed, out of which 10,700 individuals were interviewed. Most respondents (95.1%) stated that they heard about trachoma MDA and most of them replied that they got the information from health workers. Program reach ranged between 89.5% in Jimma Geneti district and 94.8% in Dirre Hinchini district. The most common mentioned reasons for not having taken azithromycin included not knowing about the campaign, fear of side effects and being absent during the MDA campaign. CONCLUSION: In this survey, four of the six districts met the target threshold (i.e. 80%) for effective coverage; Ambo rural and Jimma Geneti did not meet the target threshold.Therefore, programmatic improvements should be made for the future campaign to reach the expected thresholds while the campaign in four of the six districts should be encouraged.
format Online
Article
Text
id pubmed-6936871
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69368712020-01-07 Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017 Bekuma, Tariku Tesfaye Mosisa Kebebew, Getu Desalegn Waktole, Zelalem Markos Cafo, Jote Wirtu, Desalegn Gaddisa, Solomon PLoS Negl Trop Dis Research Article BACKGROUND: Trachoma is a contagious infection of the eye by specific strains of the bacteria Chlamydia trachomatis. It is the leading cause of blindness worldwide. Mass drug administration (MDA) with azithromycin is a cornerstone of World Health Organization (WHO)’s global effort to eliminate trachoma by 2020. This coverage survey was aimed to assess trachoma post-mass drug administration (MDA) coverage among six selected districts of East Wollega, Horo Guduru Wollega, and West Shewa zones in2017. METHODS: A community based cross-sectional coverage survey was conducted. The sample size was calculated automatically using Coverage Survey Builder (CSB) tool in microsoft excel. Thirty segments were selected per each selected districts of the three zones. A separate Results Entry Form for each district surveyed was completed, saved and uploaded directly into the online Coverage Survey Analysis Tool to estimate the surveycoverage and the program reach along with the corresponding 95% confidence limits and design effects. EPI-INFO 7.0 and SPSS version 20 was used for further analysis of survey data. RESULT: A total of 1,747 households were surveyed, out of which 10,700 individuals were interviewed. Most respondents (95.1%) stated that they heard about trachoma MDA and most of them replied that they got the information from health workers. Program reach ranged between 89.5% in Jimma Geneti district and 94.8% in Dirre Hinchini district. The most common mentioned reasons for not having taken azithromycin included not knowing about the campaign, fear of side effects and being absent during the MDA campaign. CONCLUSION: In this survey, four of the six districts met the target threshold (i.e. 80%) for effective coverage; Ambo rural and Jimma Geneti did not meet the target threshold.Therefore, programmatic improvements should be made for the future campaign to reach the expected thresholds while the campaign in four of the six districts should be encouraged. Public Library of Science 2019-12-16 /pmc/articles/PMC6936871/ /pubmed/31841516 http://dx.doi.org/10.1371/journal.pntd.0007924 Text en © 2019 Bekuma et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bekuma, Tariku Tesfaye
Mosisa Kebebew, Getu
Desalegn Waktole, Zelalem
Markos Cafo, Jote
Wirtu, Desalegn
Gaddisa, Solomon
Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017
title Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017
title_full Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017
title_fullStr Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017
title_full_unstemmed Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017
title_short Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017
title_sort coverage assessment survey following trachoma mass drug administration (mda) in six districts of oromia, western ethiopia, 2017
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936871/
https://www.ncbi.nlm.nih.gov/pubmed/31841516
http://dx.doi.org/10.1371/journal.pntd.0007924
work_keys_str_mv AT bekumatarikutesfaye coverageassessmentsurveyfollowingtrachomamassdrugadministrationmdainsixdistrictsoforomiawesternethiopia2017
AT mosisakebebewgetu coverageassessmentsurveyfollowingtrachomamassdrugadministrationmdainsixdistrictsoforomiawesternethiopia2017
AT desalegnwaktolezelalem coverageassessmentsurveyfollowingtrachomamassdrugadministrationmdainsixdistrictsoforomiawesternethiopia2017
AT markoscafojote coverageassessmentsurveyfollowingtrachomamassdrugadministrationmdainsixdistrictsoforomiawesternethiopia2017
AT wirtudesalegn coverageassessmentsurveyfollowingtrachomamassdrugadministrationmdainsixdistrictsoforomiawesternethiopia2017
AT gaddisasolomon coverageassessmentsurveyfollowingtrachomamassdrugadministrationmdainsixdistrictsoforomiawesternethiopia2017